NHS Unlocks 'Life-Changing' Walking Drug for Thousands with Multiple Sclerosis
Thousands of people living with Multiple Sclerosis (MS) in England can now access Fampridine, a 'signal booster' pill designed to significantly improve walking difficulties, following its routine rollout on the NHS starting today. This breakthrough marks a pivotal moment for patients, offering renewed independence and a tangible step towards better quality of life for a condition that often severely impacts mobility. Fampridine is the first medicine specifically designed to target walking impairment in adults with MS, a symptom that deeply affects daily living for many.

















